ScholarIQanswers from OpenAlex & ORCID
Suzanne Kamel‐Reid
ResearcherPublications, citations & collaboration network
Suzanne Kamel‐Reid is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Suzanne Kamel‐Reid have?
ScholarIQindexed works
Suzanne Kamel‐Reid has 429 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Suzanne Kamel‐Reid have?
ScholarIQcitation count
Suzanne Kamel‐Reid has 19,586 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Suzanne Kamel‐Reid?
ScholarIQh-index
Suzanne Kamel‐Reid has an h-index of 67 in OpenAlex.
What is the i10-index of Suzanne Kamel‐Reid?
ScholarIQi10-index
Suzanne Kamel‐Reid has an i10-index of 224 in OpenAlex.
What is the ORCID of Suzanne Kamel‐Reid?
ScholarIQorcid
The ORCID for Suzanne Kamel‐Reid is on the source record.
What is the OpenAlex record for Suzanne Kamel‐Reid?
ScholarIQopenalex
The OpenAlex for Suzanne Kamel‐Reid is on the source record.
What are the most-cited papers on Suzanne Kamel‐Reid?
ScholarIQmost cited works
AACR Project GENIE: Powering Precision Medicine through an International Consortium
Fabrice André, Mónica Arnedos, Alexander S. Baras, José Baselga, Philippe L. Bédard, Michael F. Berger, Mariska Bierkens, Fabien Calvo, Ethan Cerami, Debyani Chakravarty, Kristen K. Dang, Nancy E. Davidson, Catherine Del Vecchio Fitz, Semih Doğan, Raymond N. DuBois, Matthew D. Ducar, P. Andrew Futreal, Jianjiong Gao, Francisco Moacir Pinheiro Garcia, Stuart M. Gardos, Christopher D. Gocke, Benjamin Groß, Justin Guinney, Zachary Heins, Stephanie Hintzen, Hugo M. Horlings, Jan Hudeček, David M. Hyman, Suzanne Kamel‐Reid, Cyriac Kandoth, Walter Kinyua, Priti Kumari, Ritika Kundra, Marc Ladanyi, Céline Lefèbvre, Michele L. Lenoue-Newton, Eva M. Lepisto, Mia Levy, Neal I. Lindeman, James Lindsay, David Liu, Zhibin Lu, Laura E. MacConaill, Ian Maurer, David S. Maxwell, Gerrit A. Meijer, Funda Meric‐Bernstam, Christine Micheel, Clinton Miller, Gordon B. Mills, Nathanael D. Moore, Petra M. Nederlof, Larsson Omberg, John A. Orechia, Ben Ho Park, Trevor J. Pugh, Brendan Reardon, Barrett J. Rollins, Mark J. Routbort, Charles L. Sawyers, Deborah Schrag, Nikolaus Schultz, Kenna Shaw, Priyanka Shivdasani, Lillian L. Siu, David B. Solit, Gabe S. Sonke, Jean Charles Soria, Parin Sripakdeevong, Natalie Stickle, Thomas Stricker, Shawn M. Sweeney, Barry S. Taylor, Jelle J. ten Hoeve, Stacy B. Thomas, Eliezer M. Van Allen, Laura van ‘t Veer, Tony van de Velde, Harm van Tinteren, Victor E. Velculescu, Carl Virtanen, Emile E. Voest, Lucy Lu Wang, Chetna Wathoo, Stuart Watt, Celeste Yu, Thomas Yu, Emily Yu, Ahmet Zehir, Hongxin Zhang
Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome
Ming‐Sound Tsao, Akira Sakurada, Jean-Claude Cutz, Chang‐Qi Zhu, Suzanne Kamel‐Reid, Jeremy A. Squire, Ian Lorimer, Tong Zhang, Geoffrey Liu, Manijeh Daneshmand, Paula Marrano, Gilda da Cunha Santos, Alain E. Lagarde, Frank C. Richardson, Lesley Seymour, Marlo Whitehead, Keyue Ding, Joseph L. Pater, Frances A. Shepherd
Guidelines for Validation of Next-Generation Sequencing–Based Oncology Panels
Lawrence J. Jennings, Maria E. Arcila, Christopher L. Corless, Suzanne Kamel‐Reid, Ira M. Lubin, John D. Pfeifer, Robyn Temple‐Smolkin, Karl V. Voelkerding, Marina N. Nikiforova
Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group
Amit M. Oza, Laurie Elit, Ming‐Sound Tsao, Suzanne Kamel‐Reid, Jim Biagi, Diane Provencher, Walter H. Gotlieb, Paul Hoskins, Prafull Ghatage, Katia Tonkin, Helen Mackay, J. Mazurka, Joana Sederias, Percy Ivy, Janet Dancey, Elizabeth A. Eisenhauer